Skip to main content

Table 1 Comparisons of the temperature changes in tumor, RSIs of BLI at day 14 post-treatment, and apoptosis rates between groups (* p< 0.01, ** p< 0.05)

From: The intratumoral administration of ferucarbotran conjugated with doxorubicin improved therapeutic effect by magnetic hyperthermia combined with pharmacotherapy in a hepatocellular carcinoma model

  Group B vs. C Group B vs. D Group C vs. D
Temperature changes 0.009* 0.009* 0.465
RSIs of BLI 0.834 0.047** 0.009*
Apoptosis rates 0.675 0.028** 0.008*
  1. Each number in the table indicates a p-value obtained by Mann–Whitney test.